minoxidil has been researched along with Hypertrophy in 2 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to assess the efficacy and safety of minoxidil on Intima Media Thickness (IMT) on the right common carotid artery after twelve-month treatment in patient with Williams-Beuren syndrome." | 9.30 | Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trial. ( Bertholet-Thomas, A; Bouyé, P; Canterino, I; Chirossel, P; Cochat, P; Coopman, S; Di-Fillippo, S; Gilbert-Dussardier, B; Ginhoux, T; Godart, F; Grenet, G; Gueyffier, F; Kassai, B; Luong, S; Mercier, C; Pirot, F; Pivot, C; Rabilloud, M; Rossi, M; Serusclat, A; Thambo, JB, 2019) |
| "Angiotensin II (Ang II) may induce arterial hypertrophy either directly or through an increase in arterial pressure." | 7.70 | Pressure mediates angiotensin II-induced arterial hypertrophy and PDGF-A expression. ( Parker, SB; Prewitt, RL; Wade, SS, 1998) |
| "The aim of this study was to assess the efficacy and safety of minoxidil on Intima Media Thickness (IMT) on the right common carotid artery after twelve-month treatment in patient with Williams-Beuren syndrome." | 5.30 | Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trial. ( Bertholet-Thomas, A; Bouyé, P; Canterino, I; Chirossel, P; Cochat, P; Coopman, S; Di-Fillippo, S; Gilbert-Dussardier, B; Ginhoux, T; Godart, F; Grenet, G; Gueyffier, F; Kassai, B; Luong, S; Mercier, C; Pirot, F; Pivot, C; Rabilloud, M; Rossi, M; Serusclat, A; Thambo, JB, 2019) |
| "Angiotensin II (Ang II) may induce arterial hypertrophy either directly or through an increase in arterial pressure." | 3.70 | Pressure mediates angiotensin II-induced arterial hypertrophy and PDGF-A expression. ( Parker, SB; Prewitt, RL; Wade, SS, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kassai, B | 1 |
| Bouyé, P | 1 |
| Gilbert-Dussardier, B | 1 |
| Godart, F | 1 |
| Thambo, JB | 1 |
| Rossi, M | 1 |
| Cochat, P | 1 |
| Chirossel, P | 1 |
| Luong, S | 1 |
| Serusclat, A | 1 |
| Canterino, I | 1 |
| Mercier, C | 1 |
| Rabilloud, M | 1 |
| Pivot, C | 1 |
| Pirot, F | 1 |
| Ginhoux, T | 1 |
| Coopman, S | 1 |
| Grenet, G | 1 |
| Gueyffier, F | 1 |
| Di-Fillippo, S | 1 |
| Bertholet-Thomas, A | 1 |
| Parker, SB | 1 |
| Wade, SS | 1 |
| Prewitt, RL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Efficacy of Minoxidil in Children With Williams-Beuren Syndrome: a Randomized Clinical Trial.[NCT00876200] | Phase 2 | 21 participants (Actual) | Interventional | 2009-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00876200)
Timeframe: 12 months
| Intervention | mm (Mean) |
|---|---|
| Minoxidil | 0.028 |
| Placebo | 0.012 |
1 trial available for minoxidil and Hypertrophy
| Article | Year |
|---|---|
Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trial.
Topics: Adolescent; Carotid Artery, Common; Carotid Intima-Media Thickness; Child; Double-Blind Method; Elas | 2019 |
1 other study available for minoxidil and Hypertrophy
| Article | Year |
|---|---|
Pressure mediates angiotensin II-induced arterial hypertrophy and PDGF-A expression.
Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Antimetabolites; Blood Press | 1998 |